Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD ...

The Trump administration announced late last month "bold actions to tackle the autism epidemic.” President Trump said there was a possible link between acetaminophen, the active ingredient in Tylenol, ...

The U.S. Food and Drug Administration is considering approval of the drug leucovorin to treat children with cerebral folate deficiency and symptoms of autism. Kevin Pelphrey is the Harrison-Wood ...

Forbes contributors publish independent expert analyses and insights. Alison Escalante M.D. covers neurodiversity, pediatrics and parenting. The U.S. Food and Drug Administration will add an ...

The FDA initiated the approval of the prescription drug leucovorin for the treatment of autism in children. Here's what to know. On Monday, Sept. 22, the U.S. Food and Drug Administration announced ...

During a Monday press conference about various autism topics, federal health officials noted the potential for an existing cancer drug to double as therapy for the neurodevelopmental condition. FDA ...

U.S. Health Secretary Robert F Kennedy Jr. could deliver a policy win for the Trump administration in just a few months after the Food and Drug Administration enlisted GSK to help it fast-track ...

Scientists have learned more about the genetic factors that may underlie double-jointedness, also known as hypermobility, and diseases that affect connective tissue called hypermobile Ehlers-Danlos ...